Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
712,259
Value
$353.8M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026712,259$353.8M0.1%+81,641+12.9%AddedHolders
Q1 2026630,618$281.6M<0.1%+74,636+13.4%AddedHolders
Q4 2025555,982$252.1M<0.1%−217,066−28.1%ReducedHolders
Q3 2025773,048$302.8M0.1%+73,046+10.4%AddedHolders
Q2 2025700,002$311.6M0.1%−37,416−5.1%ReducedHolders
Q1 2025737,418$357.5M0.1%−125,618−14.6%ReducedHolders
Q4 2024863,036$347.5M0.1%+88,821+11.5%AddedHolders
Q3 2024774,215$360.1M0.1%+179,835+30.3%AddedHolders
Q2 2024594,380$278.6M0.1%+22,200+3.9%AddedHolders
Q1 2024572,180$239.2M0.1%+148,474+35.0%AddedHolders
Q4 2023423,706$172.4M0.1%+71,008+20.1%AddedHolders
Q3 2023352,698$122.6M0.1%−131,183−27.1%ReducedHolders
Q2 2023483,881$170.3M0.1%−58,264−10.7%ReducedHolders
Q1 2023542,145$170.8M0.1%−63,417−10.5%ReducedHolders
Q4 2022605,562$174.9M0.1%+322,784+114.1%AddedHolders
Q3 2022282,778$81.9M<0.1%−25,916−8.4%ReducedHolders
Q2 2022308,694$87.0M<0.1%−102,651−25.0%ReducedHolders
Q1 2022411,345$107.3M<0.1%+54,874+15.4%AddedHolders
Q4 2021356,471$78.3M<0.1%−146,377−29.1%ReducedHolders
Q3 2021502,848$91.2M<0.1%+54,804+12.2%AddedHolders
Q2 2021448,044$90.3M<0.1%+9,852+2.2%AddedHolders
Q1 2021438,192$94.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.